Filter posts

Health Affairs: Burden of Vaccine-Preventable Diseases

Just as flu season gears up, Health Affairs released a new study, “Modeling The Economic …

Five Oncologists Weigh in on Value Frameworks

Value Frameworks, which attempt to quantify the value of a medicine, have been a hot …

BIO Investor Forum Session on Advancing Immuno–Oncology

At the 2016 BIO Investor Forum, the first session held was titled “The Intersection of …

Lawsuit Against UnitedHealth Put Insurers’ Practices Under Scrutiny

Reuters reports that UnitedHealth Group, the nation’s largest insurer, has been sued by three patients …

Astellas Expands Advocacy Engagement with Focused Outreach

Astellas recognizes the crucial role that patient groups play in enhancing and extending the lives …

Closing the Gender Gap in Biotech through SBIR/STTR Funding

Although progress has been made, there is no denying the biotech industry continues to have …

Riding Coast to Coast for Cancer Patients

For 21 days in September, 80 members of Bristol-Myers Squibb’s (BMS) oncology team will cross …

Cancer Docs Weigh in on Medicare Part B Demo

This week, American Society of Clinical Oncology (ASCO) President Daniel Hayes, MD and CEO Clifford …

2016 BIO Animal Biotech Summit Day One Highlights

BIO concluded its 2016 Animal Biotech Summit on Friday, September 23, 2016. BIO chose “One Health” …

All Pharma Wants to Be “Patient-Centric” – What Does That Really Mean?

The concept “patient-centricity” has become a pharmaceutical industry buzzword in recent years, making it difficult …